P
hospholipases A 2 (PLA 2 ; 3 EC 3.1.1.4.) cleave fatty acids from the sn-2 position of phospholipids, yielding free fatty acids and lysophospholipid. PLA 2 s have been classified into various groups based on the molecular structure of the enzyme protein (1) . Group IIA PLA 2 is a small molecular mass (14 kDa) secretory enzyme and is highly bactericidal against Gram-positive bacteria in vitro (2) . Overexpression of group IIA PLA 2 in transgenic mice results in decreased mortality in experimental Staphylococcus aureus infection and improved clearance of bacteria from organs and body fluids of the experimental animals, emphasizing the role of this enzyme in innate immunity (3) . High concentrations of group IIA PLA 2 are found in tears (4) , where the majority of bactericidal action is due to group IIA PLA 2 (5) . The bactericidal potency of rabbit (2) , mouse (6) , and human (3) group IIA PLA 2 is basically directed against Gram-positive bacteria. However, Harwig and coworkers showed that murine intestinal group IIA PLA 2 is bactericidal against some Gram-negative bacteria, such as Escherichia coli and Salmonella typhimurium (6) .
Group V PLA 2 is a novel type of PLA 2 expressed in, e.g., mouse heart (7) and macrophage-derived cells (8) , where the enzyme seems to have a role in mobilization of arachidonic acid (8) . Moreover, LPS and platelet-activating factor-induced sphingomyelin synthesis is dependent on group V PLA 2 in the latter cells (9) .
Lately, the enzymatic properties of group V PLA 2 have been thoroughly characterized (7, 10, 11) .
Macrophages phagocytize and kill invading bacteria at the sites of bacterial infection, but the mechanisms of bacterial killing by these cells are poorly defined. The purpose of the present study was to evaluate the possible role of group V PLA 2 in killing various antibiotic-resistant and sensitive bacterial strains. For this purpose we used recombinant rat group IIA and V PLA 2 s that were folded in vitro to obtain full enzymatic activity (11) and measured their bactericidal properties in vitro. Our results show that rat group IIA PLA 2 is highly bactericidal against Staphylococcus aureus, methicillin-resistant S. aureus, and Listeria monocytogenes, moderately bactericidal against Enterococcus faecalis and Enterococcus faecium and shows a weak bactericidal activity against E. coli. Group V PLA 2 is bactericidal against L. monocytogenes, methicillin-sensitive S. aureus, E. faecalis, and E. faecium. Thus, group V PLA 2 seems to be a novel antibacterial enzyme, but weaker in antibacterial potency than group IIA PLA 2 .
Materials and Methods

Production of rat group IIA and group V PLA 2 s
Rat group IIA and V PLA 2 s were produced by recombinant expression in E. coli and were folded in vitro as described previously (11) . The isoelectric points of the group IIA and group V PLA 2 s were 9.1 and 8.3, respectively. For the studies of antibacterial potency, both group IIA and V PLA 2 s were diluted in sterile deionized water to an initial concentration of 61 g/ml.
Killing of bacteria in vitro
The bacteria used were S. aureus (American Type Culture Collection, Manassas, VA; ATCC 25923 and MRSA 27R), L. monocytogenes (RHD 1343), E. faecalis (Van B, ATCC 51299), E. faecium (VRE, Van A, World Health Organization, Geneva, Switzerland), and E. coli (ATCC 25922). Bacteria were first incubated in 100 ml of brain heart infusion broth (BHIB; Difco, Detroit, MI) at 37°C for 210 min. Thereafter, bacteria were centrifuged at 6°C for 10 min at 2000 ϫ g in an Eppendorf centrifuge 5810R. The pellets were suspended in 10 ml of sterile saline and centrifuged. The washing step was repeated twice. Then, the pellets were suspended in saline, and the OD at 650 nm (OD 650 ) of the suspension was adjusted to ϳ0.500 by diluting with steriline saline. This value is equivalent with ϳ3 ϫ 10 8 bacteria/ml. OD 650 was measured with an Ultrospec III spectrophotometer (Pharmacia, Piscataway, NJ). One microliter of the suspension was added to 500 l of HEPES buffer (20 mmol/L HEPES, 2.0 mmol/L Ca 2ϩ , and 10 mg/ml BSA, pH 7.4) and shaken. The 0 min sample was taken from this dilution. Twenty microliters of this suspension were added to four tubes with 20 l of sterile saline containing 61, 6.1, 0.61, and 0.061 g/ml PLA 2 and one tube with 20 l sterile saline only. The resulting medium thus contained 10 mmol/L HEPES, 1 mmol/L Ca 2ϩ , 5 mg/ml BSA, and 30.5, 3.05, 0.305, or 0.0305 g/ml PLA 2 , respectively. Bacteria were then incubated at 37°C, and 5-l samples were taken at 20, 60, and 120 min. The samples taken were diluted in sterile saline and grown on brain heart infusion agar (Difco) at 37°C. The number of live bacteria in growth medium at each time point was determined by measuring the CFU FIGURE 1. Killing of bacteria in vitro by group IIA PLA 2 . Samples were taken after incubation for 20, 60, and 120 min and cultivated on agar. CFUs were counted after 24 h. The bactericidal effect of group IIA PLA 2 was strongest against L. monocytogenes (A). A clear effect was also seen against methicillin-sensitive S. aureus strain (B), methicillin resistant S. aureus strain (C), E. faecium (D), and E. faecalis (E). Against E. coli, a bacteriostatic effect was seen with high concentration of group IIA PLA 2 (F).
at 24 h. All bactericidity tests for group IIA and group V PLA 2 s were performed twice with each bacterium.
Determining the effect of nutrition and salt concentration on bactericidal effect of PLA 2 s
To determine the possible effects of the composition of culture medium on antibacterial potency of the two PLA 2 s, S. aureus was cultured as described above in medium containing 10 mmol/L HEPES and 1 mmol/L Ca 2ϩ (pH 7.4) with varying amounts of NaCl (0.0 -0.9%), BSA (0 -5 mg/ml), and BHIB (0 -5%). Control medium contained 10 mmol/L HEPES and 1 mmol/L Ca 2ϩ (pH 7.4) only. Solutions containing 3.05-30.5 g/ml of group IIA or group V PLA 2 were prepared for each medium.
Cytotoxicity test
To test the possible cytotoxic effects of group IIA and group V PLA 2 s on eukaryotic cell, a trypan blue exclusion test was performed using HEK cells (human embryonic kidney cells, ATCC CRL-1573). Solutions containing 10 g/ml of group IIA or group V PLA 2 in DMEM were prepared by mixing 200 l of PLA 2 solution (61 g/ml in sterile saline) or saline (negative control) with 1 ml of DMEM. A 10% (v/v) solution of ethanol in DMEM was used as a positive control for cytotoxicity. Approximately 1 ϫ 10 4 cells were added to the wells of a 96-well cell culture cluster (Costar/ Corning, Corning, NY). The cells were first incubated in 100 l of DMEM for 24 h; thereafter the medium was removed, and 100 l of the test solution was pipetted into each well. After 4, 12, and 24 h of incubation at 37°C under 5% CO 2 , the medium containing detached cells was transferred from the wells into test tubes. The remaining cells were detached from the wells by trypsin treatment and added to the test tubes. Forty microliters of 0.5% trypan blue dye solution was added to the tube, and after 5 min the cells were centrifuged at 100 ϫ g using an Eppendorf 5417R centrifuge. The supernatant was carefully removed, and the cells were resuspended in 100 l of DMEM. The ratio between viable (nondyed) and nonviable (dyed) cells was determined by counting 200 cells in a Bürker chamber. The cytotoxicity test was performed three times for each treatment. 
aureus (C). No effect was seen against E. coli (F).
Results
Bactericidal properties of rat recombinant group IIA and V PLA 2 s in vitro
Group IIA PLA 2 was bactericidal against all the bacteria tested (Fig. 1) . Group V PLA 2 showed antibacterial activity against the Gram-positive bacteria (Fig. 2) . With the highest doses of PLA 2 s tested (30.5 g/ml of either group IIA or V PLA 2 ), the most dramatic effect was seen on L. monocytogenes and E. faecium; after 20 min, Ͼ99.5% of the bacteria died in the presence of either PLA 2 s. The antibacterial effect of group IIA PLA 2 was remarkable against E. faecalis and S. aureus. Over 98% of the bacteria died at 20 min at the highest doses of group IIA PLA 2 . In the presence of group V PLA 2 , 90% of S. aureus and 99.8% of E. faecalis died in 2 h. Over 99% of MRSA died in 1 h in the presence of group IIA PLA 2 . The antibacterial potency of group V PLA 2 against MRSA was somewhat weaker than that of group IIA PLA 2 ; 85% of MRSA died in 2 h at a corresponding dose of the enzyme. Group IIA PLA 2 had a bacteriostatic effect against E. coli: 91% of the bacteria were alive at 120 min, whereas in the absence of group IIA PLA 2 , the number of the bacteria increased almost 3-fold. Group V PLA 2 had neither bacteriostatic nor bactericidal effect against E. coli. The dose responses of the bactericidal activity of both PLA 2 s against all microbes tested are presented in Table I .
Effect of nutrition and salt concentration on bactericidal effect of PLA 2 s
The presence or the absence of isotonic saline did not change the bactericidal effect of group IIA and group V PLA 2 s against S. aureus (data not shown). No difference in the bactericidal activity was observed between culture medium containing 5 mg/ml and 0.5 mg/ml of BSA (data not shown). The bacterial viability in the medium depended on the presence of BSA in the medium (presumably the bacteria used BSA for their nutrition). When BSA was omitted from the culture medium, the bactericidal effect of group IIA PLA 2 decreased somewhat (Fig. 3A) . On the contrary, the bactericidal effect of group V PLA 2 increased when BSA was omitted from the reaction mixture (Fig. 3B) . BHIB increased the growth of the bacteria significantly. Without BHIB, the antibacterial effects of group IIA and group V PLA 2 were observed with the concentrations of 3.05 g/ml of the enzyme. In the presence of BHIB, group IIA and group V PLA 2 s were antibacterial only at the highest concentrations of the enzymes (30.5 g/ml; Fig. 3, C and D) .
Cytotoxicity of group IIA and group V PLA 2
The percentage of viable HEK cells in treatment medium containing group IIA PLA 2 , group V PLA 2 , or sterile saline was ϳ95% at 24 h. No difference was seen among these three groups. In the treatment medium containing 10% (v/v) ethanol (positive control for cytotoxicity), 60% of the cells died in 24 h. The results show that neither group IIA PLA 2 nor group V PLA 2 is cytotoxic to mammalian cells.
Discussion
Group V PLA 2 is a novel type of 14-kDa secretory PLA 2 . The amino acid sequence of group V has significant homology with that of group IIA PLA 2 (12, 13) . It has been proposed that the genes of groups V, IIA, and IIC share a common origin (14) . The bactericidal properties of group V PLA 2 have not been tested previously. Rat recombinant group V PLA 2 has a strong affinity to phosphatidylcholine (PC) and displays activity on PC micelles and liposomes. These properties make group V PLA 2 suitable for action on biological membranes (11) . The same kinds of results have been published for human group V PLA 2 (10). Human group V PLA 2 hydrolyses phosphatidylethanolamine (PE) vesicles more effectively than PC vesicles. However, in mixed vesicles, the hydrolysis of PE and PC by group V PLA 2 is equivalent (7). Human group V PLA 2 catalyzes the hydrolysis of PC over 100 times more effectively than human group IIA PLA 2 (10) . Rat group V PLA 2 hydrolyses PC more effectively than rat group IIA PLA 2 (11). Thus, it seems that rat and human group V PLA 2 s share some biochemical and functional properties. The major structural components of the cell walls of Gram-negative and Gram-positive bacteria are PE and phosphatidylglycerol (PG), respectively. The activities of rat recombinant group IIA and group V PLA 2 s have not been tested on these two phospholipids. However, they have been tested on phosphatidylglycol (PGlo), which has the same charge, size, and interfacial properties as PG (11) . The maximal velocity of group IIA PLA 2 on PGlo is almost 20-fold higher than that of group V PLA 2 . Han and coworkers have calculated the specificity constants (k cat /K m ) of human group IIA and V PLA 2 s (10). The value for group V PLA 2 on PE is almost 10-fold higher than that for group IIA PLA 2 . It is possible that group IIA PLA 2 hydrolyzes bacterial PG, whereas the main target of group V PLA 2 may be bacterial PE and eukaryotic membrane phospholipids, such as PC. The bactericidal properties of group V PLA 2 and its localization in murine macrophages (8) suggest an involvement of group V PLA 2 in immunity against bacteria. The actual role of group V PLA 2 in macrophages requires further investigation.
The bactericidal effect of group IIA PLA 2 is highest against bacteria in the phase of logarithmic growth (15) . This probably reflects the increased vulnerability of dividing bacteria and the ability of group IIA PLA 2 to reach the bacterial plasma membrane through the dividing cell wall. Whether the effect of group V PLA 2 is dependent on the phase of the bacterial growth cycle remains to be established. The finding that the bactericidal effect of group IIA PLA 2 was diminished in culture medium containing no BSA correlates to the earlier results of Foreman-Wykert and coworkers (16) , but the rational of this effect is not fully understood.
The MBC values for group IIA and V PLA 2 s against the microbes tested here are ϳ1-50 g/ml. The serum PLA 2 concentrations in severe inflammatory conditions such as typhoid fever (17) and systemic fungal infections (18) have been reported to be ϳ1-5 g/ml. In normal human tears the concentration of group IIA PLA 2 exceeds 30 g/ml (4). In the present study L. monocytogenes and S. aureus were the most sensitive microbes to group IIA PLA 2 ; 3.05 g/ml of group IIA PLA 2 was bactericidal against these bacteria. These observations suggest that the concentrations of group IIA PLA 2 present in human serum in severe inflammatory diseases may kill bacteria. Secretory group IIA PLA 2 has been shown not to be cytotoxic to otherwise healthy cells (19, 20) , whereas the cytosolic group IV PLA 2 may have cytotoxic properties (21) . The present results indicate that neither group IIA PLA 2 nor group V PLA 2 have cytotoxic properties. We propose that both group IIA and group V PLA 2 s may be considered future therapeutic agents against bacterial infections.
